Journal of Bone and Joint Surgery, 1974;56:1552-1562.
© 1974 by The Journal of Bone and Joint Surgery, Inc
Comparison of Warfarin, Low-Molecular-Weight Dextran, Aspirin, and Subcutaneous Heparin in Prevention of Venous Thromboembolism following Total Hip Replacement
WILLIAM H. HARRIS M.D.1,
EDWIN W. SALZMAN M.D.1,
CHRISTOS ATHANASOULIS M.D.1,
ARTHUR C. WALTMAN M.D.1,
STANLEY BAUM M.D.1, and
ROMAN W. DESANCTIS M.D.1
1 From the Departments of Orthopaedic Surgery, Radiology, and Medicine of the Massachusetts General Hospital; The Department of Surgery of the Beth Israel Hospital; and the Departments of Orthopaedic Surgery, Radiology, Surgery, and Medicine of the Harvard Medical School, Boston
In a prospective study of 187 patients without known prior phlebitis who underwent total hip replacement, we compared the efficacy of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin for prevention of postoperative venous thrombi. Detection of thrombi was by phlebography. Warfarin dextran, and aspirin were superior to heparin. There was no significant difference between the effects of warfarin, dextran, and aspirin on the number of patients with fresh thrombi. In reducing the number of thrombi formed, warfarin and dextran were superior to aspirin. For reduction of the prevalence of thrombi in the thigh, the three drugs were equally effective. Significantly fewer bleeding complications occurred with aspirin than with warfarin. Even in patients who received warfarin, dextran, or aspirin, the prevalence of fresh thrombi was high. Thrombi often formed in the thigh without an associated calf thrombus. Fifty-one of fifty-six episodes of thromboembolic disease were clinically silent at the time of detection. The prophylactic use of warfarin or aspirin, followed by warfarin treatment if a thrombus was detected on phlebograms, provided effective protection against pulmonary embolism.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. R. Lieberman and W. K. Hsu
Prevention of Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty
J. Bone Joint Surg. Am.,
September 1, 2005;
87(9):
2097 - 2112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Geerts, G. F. Pineo, J. A. Heit, D. Bergqvist, M. R. Lassen, C. W. Colwell, and J. G. Ray
Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest,
September 1, 2004;
126(3_suppl):
338S - 400S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Athanasoulis
Vascular Radiology: Looking into the Past to Learn about the Future
Radiology,
February 1, 2001;
218(2):
317 - 322.
[Full Text]
|
 |
|

|
 |

|
 |
 
W. H. Geerts, J. A. Heit, G. P. Clagett, G. F. Pineo, C. W. Colwell, F. A. Anderson Jr., and H. B. Wheeler
Prevention of Venous Thromboembolism
Chest,
January 1, 2001;
119(1_suppl):
132S - 175S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Freedman, K. R. Brookenthal, R. H. Fitzgerald, S. Williams, and J. H. Lonner
A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty
J. Bone Joint Surg. Am.,
July 1, 2000;
82(7):
929 - 929.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. J. DELLA VALLE, L. M. JAZRAWI, J. IDJADI, R. N. HIEBERT, S. A. STUCHIN, D. J. STEIGER, and P. E. DI CESARE
Anticoagulant Treatment of Thromboembolism with Intravenous Heparin Therapy in the Early Postoperative Period Following Total Joint Arthroplasty
J. Bone Joint Surg. Am.,
February 1, 2000;
82(2):
207 - 12.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. W. COLWELL, D. K. COLLIS, R. PAULSON, J. W. McCUTCHEN, G. T. BIGLER, S. LUTZ, and M. E. HARDWICK
Comparison of Enoxaparin and Warfarin for the Prevention of Venous Thromboembolic Disease After Total Hip Arthroplasty. Evaluation During Hospitalization and Three Months After Discharge
J. Bone Joint Surg. Am.,
July 1, 1999;
81(7):
932 - 40.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Agnelli
Postdischarge prophylaxis for venous thromboembolism among high-risk surgery patients
Vascular Medicine,
February 1, 1998;
3(1):
51 - 56.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. FRANCIS, V. D. PELLEGRINI JR., S. TOTTERMAN, A. D. BOYD JR., V. J. MARDER, K. M. LIEBERT, B. N. STULBERG, D. C. AYERS, A. ROSENBERG, C. KESSLER, et al.
Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin and Dalteparin
J. Bone Joint Surg. Am.,
September 1, 1997;
79(9):
1365 - 72.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. H. WESTRICH and T. P. SCULCO
Prophylaxis against Deep Venous Thrombosis after Total Knee Arthroplasty. Pneumatic Plantar Compression and Aspirin Compared with Aspirin Alone
J. Bone Joint Surg. Am.,
June 1, 1996;
78(6):
826 - 34.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Klein and S. G. Pauker
Recurrent Deep Venous Thrombosis in Pregnancy: Analysis of the Risks and Benefits of Anticoagulation
Med Decis Making,
January 1, 1981;
1(2):
181 - 202.
[PDF]
|
 |
|
|